Lung cancer often is associated with significant morbidity, which has a detrimental effect on quality of life. Supportive care plays a central role in the multimodal treatment of lung cancer. Palliation of symptoms often improves quality of life and compliance with therapy. New developments in supportive care, reviewed here, include management of symptoms of the disease, such as respiratory problems, pain, and cachexia, as well as effects of treatment, including chemotherapy-induced nausea and vomiting, neutropenia, anemia, and mucositis. In the past few years, significant advances have been made in this field; however, palliation of the symptoms of lung cancer remains an area of active investigation.
aDepartment of Medicine, Columbia University Medical Center, 177 Fort Washington Avenue, MHB6-435, New York, NY 10032, USA
bDepartment of Medicine, Columbia University Medical Center, 161 Fort Washington Avenue, HIP 9-909, New York, NY 10032, USA
Corresponding author
Dr. Raftopoulos received more than $2000 from Merck in 2003 for speaking fees.